Company profile EBS

Emergent Biosolutions Inc
Description of the company is not available.
Quarter analysis & expected interestLast update: February 08 2024 21:04:02.

After 39 days of this quarter the interest is at 32.0. Based on that we can calculate that during remaining 52 days it will total up to 75.0.
Emergent BioSolutions expected interest is significantly lower compared to same quarter last year (-59.2%) but similar to previous quarter.

YearQ1Q2Q3Q4
201980
111
38.8% QoQ
116
4.5% QoQ
89
-23.3% QoQ
2020 134
67.5% YoY 50.6% QoQ
308
177.5% YoY 129.9% QoQ
263
126.7% YoY -14.6% QoQ
175
96.6% YoY -33.5% QoQ
2021 336
150.7% YoY 92.0% QoQ
410
33.1% YoY 22.0% QoQ
132
-49.8% YoY -67.8% QoQ
132
-24.6% YoY 0.0% QoQ
2022 114
-66.1% YoY -13.6% QoQ
149
-63.7% YoY 30.7% QoQ
131
-0.8% YoY -12.1% QoQ
103
-22.0% YoY -21.4% QoQ
2023 184
61.4% YoY 78.6% QoQ
164
10.1% YoY -10.9% QoQ
179
36.6% YoY 9.1% QoQ
117
13.6% YoY -34.6% QoQ
2024 32
-82.6% YoY -72.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Emergent BioSolutions search interestLast update: February 08 2024 21:04:02.
Correlation coefficient between keyword and revenue is 0.2
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 21:04:07.

The average 5 years interest of Emergent BioSolutions was 13.25 per week.
The last year interest of Emergent BioSolutions compared to the last 5 years has changed by -10.57%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 44.69%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 21:04:15.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
Emergent BioSolutions vaccines expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
2019103
229
122.3% QoQ
58
-74.7% QoQ
0
-100.0% QoQ
2020 51
-50.5% YoY inf% QoQ
71
-69.0% YoY 39.2% QoQ
29
-50.0% YoY -59.2% QoQ
125
inf% YoY 331.0% QoQ
2021 106
107.8% YoY -15.2% QoQ
155
118.3% YoY 46.2% QoQ
100
244.8% YoY -35.5% QoQ
125
0.0% YoY 25.0% QoQ
2022 52
-50.9% YoY -58.4% QoQ
71
-54.2% YoY 36.5% QoQ
36
-64.0% YoY -49.3% QoQ
17
-86.4% YoY -52.8% QoQ
2023 52
0.0% YoY 205.9% QoQ
42
-40.8% YoY -19.2% QoQ
143
297.2% YoY 240.5% QoQ
113
564.7% YoY -21.0% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Emergent BioSolutions vaccines search interestLast update: February 08 2024 21:04:12.
Correlation coefficient between keyword and revenue is 0.21
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 21:04:18.

The average 5 years interest of Emergent BioSolutions vaccines was 6.43 per week.
The last year interest of Emergent BioSolutions vaccines compared to the last 5 years has changed by 4.67%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by -10.27%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Emergent BioSolutions monoclonal antibodies to provide analysis

Correlation between past revenue and Emergent BioSolutions monoclonal antibodies search interest

There is not enough data for Emergent BioSolutions monoclonal antibodies to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Emergent BioSolutions monoclonal antibodies to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Emergent BioSolutions anthrax vaccine to provide analysis

Correlation between past revenue and Emergent BioSolutions anthrax vaccine search interest

There is not enough data for Emergent BioSolutions anthrax vaccine to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Emergent BioSolutions anthrax vaccine to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Emergent BioSolutions emergency treatments to provide analysis

Correlation between past revenue and Emergent BioSolutions emergency treatments search interest

There is not enough data for Emergent BioSolutions emergency treatments to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Emergent BioSolutions emergency treatments to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Emergent BioSolutions opioid overdose treatment to provide analysis

Correlation between past revenue and Emergent BioSolutions opioid overdose treatment search interest

There is not enough data for Emergent BioSolutions opioid overdose treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Emergent BioSolutions opioid overdose treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Emergent BioSolutions typhoid fever vaccine to provide analysis

Correlation between past revenue and Emergent BioSolutions typhoid fever vaccine search interest

There is not enough data for Emergent BioSolutions typhoid fever vaccine to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Emergent BioSolutions typhoid fever vaccine to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Emergent BioSolutions contract development and manufacturing to provide analysis

Correlation between past revenue and Emergent BioSolutions contract development and manufacturing search interest

There is not enough data for Emergent BioSolutions contract development and manufacturing to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Emergent BioSolutions contract development and manufacturing to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 21:04:26.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
Emergent BioSolutions news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
2019187
19
-89.8% QoQ
200
952.6% QoQ
19
-90.5% QoQ
2020 151
-19.3% YoY 694.7% QoQ
186
878.9% YoY 23.2% QoQ
235
17.5% YoY 26.3% QoQ
16
-15.8% YoY -93.2% QoQ
2021 122
-19.2% YoY 662.5% QoQ
130
-30.1% YoY 6.6% QoQ
127
-46.0% YoY -2.3% QoQ
55
243.8% YoY -56.7% QoQ
2022 14
-88.5% YoY -74.5% QoQ
134
3.1% YoY 857.1% QoQ
38
-70.1% YoY -71.6% QoQ
49
-10.9% YoY 28.9% QoQ
2023 114
714.3% YoY 132.7% QoQ
42
-68.7% YoY -63.2% QoQ
118
210.5% YoY 181.0% QoQ
88
79.6% YoY -25.4% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Emergent BioSolutions news search interestLast update: February 08 2024 21:04:26.
Correlation coefficient between keyword and revenue is -0.23
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 21:04:27.

The average 5 years interest of Emergent BioSolutions news was 7.83 per week.
The last year interest of Emergent BioSolutions news compared to the last 5 years has changed by -22.61%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -35.05%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 21:04:39.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
Emergent BioSolutions stock price expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
20190
134
inf% QoQ
85
-36.6% QoQ
90
5.9% QoQ
2020 83
inf% YoY -7.8% QoQ
221
64.9% YoY 166.3% QoQ
242
184.7% YoY 9.5% QoQ
198
120.0% YoY -18.2% QoQ
2021 162
95.2% YoY -18.2% QoQ
170
-23.1% YoY 4.9% QoQ
74
-69.4% YoY -56.5% QoQ
237
19.7% YoY 220.3% QoQ
2022 146
-9.9% YoY -38.4% QoQ
19
-88.8% YoY -87.0% QoQ
108
45.9% YoY 468.4% QoQ
0
-100.0% YoY -100.0% QoQ
2023 101
-30.8% YoY inf% QoQ
105
452.6% YoY 4.0% QoQ
323
199.1% YoY 207.6% QoQ
23
inf% YoY -92.9% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Emergent BioSolutions stock price search interestLast update: February 08 2024 21:04:38.
Correlation coefficient between keyword and revenue is 0.66
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 21:04:41.

The average 5 years interest of Emergent BioSolutions stock price was 9.66 per week.
The last year interest of Emergent BioSolutions stock price compared to the last 5 years has changed by 1.76%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 65.49%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for EBS
Earnings date: 2024-02-22 After close
Company name: Emergent Biosolutions Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-11T11:53:49+0000

CNBC
Hantavirus cases spark surge in pharma and biotech stocks — here’s why

2026-04-30T20:30:00Z

GlobeNewswire
Emergent BioSolutions Reports First Quarter 2026 Financial Results

2026-04-30T11:55:00Z

GlobeNewswire
Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox

2026-04-29T11:35:00Z

GlobeNewswire
Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142

2026-04-29T10:53:56Z

GlobeNewswire
Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help Save Lives

2026-04-28T12:01:00Z

GlobeNewswire
Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States

2026-04-16T20:05:00Z

GlobeNewswire
Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility

2026-04-16T20:05:00Z

GlobeNewswire
Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026

2026-04-09T20:25:00Z

GlobeNewswire
Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program

2026-04-07T12:05:00Z

GlobeNewswire
Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness

2026-04-02T12:00:00Z

GlobeNewswire
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences

2026-03-25T20:15:00Z

GlobeNewswire
Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical Countermeasures

2026-03-09T10:37:36Z

Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Emergent BioSolutions, Lowers Price Target to $12

2026-03-03T13:00:00Z

GlobeNewswire
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors

2026-02-26T21:05:00Z

GlobeNewswire
Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results